Revenue
2021
2022
2023
2024
2025
Tenon Medical, Inc. (TNON)
Price—Loading quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $3.9M | $3.3M | $2.9M | $691,000 | $160,000 |
| Gross profit | $2.4M | $1.7M | $1.2M | −$641,000 | $105,000 |
| Research & development | $2.1M | $2.6M | $3.2M | $2.8M | $1.7M |
| Operating expenses | $15.2M | $15.5M | $17.0M | $18.1M | $6.6M |
| Operating income | −$12.8M | −$13.8M | −$15.7M | −$18.7M | −$6.5M |
| EBITDAderived | −$12.5M | −$13.4M | −$15.5M | −$18.6M | — |
| Net income | −$12.6M | −$13.7M | −$15.6M | −$18.9M | −$7.0M |
| Basic EPSper diluted share | -$1.70 | -$11.26 | -$68.64 | -$23.62 | -$7.81 |
| Diluted EPSper diluted share | -$1.70 | -$11.26 | -$68.64 | -$23.62 | -$7.81 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Nov 14, 2025Form 4 | FOSTER STEVEN MCEO and President | BuyCommon stock | 19.5K | — | — | 22.9K |
| Nov 14, 2025Form 4 | FOSTER STEVEN MCEO and President | BuyCommon Stock Purchase Warrant · derivative | 19.5K | — | — | 19.5K |
| Nov 14, 2025Form 4 | Geist Wyatt D.Chief Innovation Officer | BuyCommon stock | 19.5K | — | — | 157.6K |
| Nov 14, 2025Form 4 | Geist Wyatt D.Chief Innovation Officer | BuyCommon Stock Purchase Warrant · derivative | 19.5K | — | — | 19.5K |
| Nov 14, 2025Form 4 | Grawey Nathaniel A.Chief Commercial Officer | BuyCommon stock | 101.2K | — | — | 239.3K |